The estimated Net Worth of Heidi L Wagner is at least $1.76 millió dollars as of 27 February 2018. Ms. Wagner owns over 698 units of Wave Life Sciences stock worth over $289,926 and over the last 9 years she sold WVE stock worth over $1,211,298. In addition, she makes $258,281 as Independent Director at Wave Life Sciences.
Heidi has made over 14 trades of the Wave Life Sciences stock since 2016, according to the Form 4 filled with the SEC. Most recently she sold 698 units of WVE stock worth $83,306 on 27 February 2018.
The largest trade she's ever made was selling 2,108 units of Wave Life Sciences stock on 4 February 2016 worth over $297,080. On average, Heidi trades about 451 units every 36 days since 2015. As of 27 February 2018 she still owns at least 49,140 units of Wave Life Sciences stock.
You can see the complete history of Ms. Wagner stock trades at the bottom of the page.
Heidi L. Wagner J.D. serves as Independent Director of the Company. is Independent Director of the Company. Ms. Wagner currently serves as Senior Vice President, Government Affairs and Policy at Global Blood Therapeutics, Inc., where she has worked since 2018. Prior to joining Global Blood Therapeutics, Ms. Wagner served as Senior Vice President, Global Governmental Affairs at Alexion Pharmaceuticals, Inc. from 2012 to 2018, and as Vice President, Global Government Affairs from 2009 to 2012. Ms. Wagner held the role of Senior Director of Government Affairs at Genentech, Inc. from 2000 to 2009, and as Director, Government Affairs from 1998 to 1999. Prior to that time, she served as Health Policy Director and Consultant at Healthcare Leadership Council, and in various roles at Epstein Becker & Green and Groom & Nordberg, and the U.S. House of Representatives. Ms. Wagner currently serves as a member of the board of directors of the American Kidney Fund, as a Trustee of the University of Colorado Foundation, and as an advisory board member of the University of Colorado, College of Media, Communication and Information. From 2015 to 2018, she also served as a member of the board of directors of the European Confederation of Pharmaceutical Entrepreneurs. Ms. Wagner earned a J.D. from George Mason University School of Law and received a Bachelor of Science in Journalism and Mass Communication from the University of Colorado.
As the Independent Director of Wave Life Sciences, the total compensation of Heidi Wagner at Wave Life Sciences is $258,281. There are 10 executives at Wave Life Sciences getting paid more, with Paul Bolno having the highest compensation of $3,581,530.
Heidi Wagner is 55, she's been the Independent Director of Wave Life Sciences since 2019. There are 6 older and 12 younger executives at Wave Life Sciences. The oldest executive at Wave Life Sciences Ltd. is Koji Miura, 71, who is the Independent Director.
Heidi's mailing address filed with the SEC is C/O WAVE LIFE SCIENCES LTD.,, 733 CONCORD AVE., CAMBRIDGE, MA, 02138.
Over the last 9 years, insiders at Wave Life Sciences have traded over $19,158,839 worth of Wave Life Sciences stock and bought 18,619,108 units worth $128,204,225 . The most active insiders traders include Plc Gsk, Capital Management, L.P.Ra ... és Capital Management, Llc Kol.... On average, Wave Life Sciences executives and independent directors trade stock every 43 days with the average trade being worth of $1,569,819. The most recent stock trade was executed by Paul Bolno on 21 August 2024, trading 48,366 units of WVE stock currently worth $279,555.
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
Wave Life Sciences executives and other stock owners filed with the SEC include: